CBDBY Statistics

Total Valuation

CBDBY has a market cap or net worth of 246.41 million. The enterprise value is 1.55 billion.

Market Cap	246.41M
Enterprise Value	1.55B

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+39.75%
Shares Change (QoQ)	-18.50%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	191.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.07
PB Ratio	0.52
P/TBV Ratio	1.18
P/FCF Ratio	1.92
P/OCF Ratio	1.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.02, with an EV/FCF ratio of 12.02.

EV / Earnings	-4.68
EV / Sales	0.44
EV / EBITDA	7.02
EV / EBIT	25.80
EV / FCF	12.02

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 3.42.

Current Ratio	0.95
Quick Ratio	0.51
Debt / Equity	3.42
Debt / EBITDA	7.85
Debt / FCF	12.52
Interest Coverage	0.24

Financial Efficiency

Return on equity (ROE) is -36.37% and return on invested capital (ROIC) is 1.29%.

Return on Equity (ROE)	-36.37%
Return on Assets (ROA)	0.83%
Return on Invested Capital (ROIC)	1.29%
Return on Capital Employed (ROCE)	1.98%
Revenue Per Employee	31,964
Profits Per Employee	-3,003
Employee Count	110,000
Asset Turnover	1.00
Inventory Turnover	7.08

Taxes

Income Tax	-33.59M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.62% in the last 52 weeks. The beta is 1.37, so CBDBY's price volatility has been higher than the market average.

Beta (5Y)	1.37
52-Week Price Change	-5.62%
50-Day Moving Average	0.55
200-Day Moving Average	0.48
Relative Strength Index (RSI)	40.35
Average Volume (20 Days)	11,346

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CBDBY had revenue of 3.52 billion and -330.35 million in losses. Loss per share was -0.67.

Revenue	3.52B
Gross Profit	964.80M
Operating Income	46.80M
Pretax Income	-263.91M
Net Income	-330.35M
EBITDA	120.58M
EBIT	46.80M
Loss Per Share	-0.67

Full Income Statement

Balance Sheet

The company has 327.60 million in cash and 1.61 billion in debt, giving a net cash position of -1.28 billion.

Cash & Cash Equivalents	327.60M
Total Debt	1.61B
Net Cash	-1.28B
Net Cash Per Share	n/a
Equity (Book Value)	470.56M
Book Value Per Share	0.96
Working Capital	-54.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 246.11 million and capital expenditures -117.46 million, giving a free cash flow of 128.65 million.

Operating Cash Flow	246.11M
Capital Expenditures	-117.46M
Free Cash Flow	128.65M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.44%, with operating and profit margins of 1.33% and -9.40%.

Gross Margin	27.44%
Operating Margin	1.33%
Pretax Margin	-7.51%
Profit Margin	-9.40%
EBITDA Margin	3.43%
EBIT Margin	1.33%
FCF Margin	3.66%

Dividends & Yields

CBDBY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.75%
Shareholder Yield	n/a
Earnings Yield	-134.06%
FCF Yield	52.21%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 18, 2010. It was a forward split with a ratio of 2.

Last Split Date	Oct 18, 2010
Split Type	Forward
Split Ratio	2

Scores

CBDBY has an Altman Z-Score of 1.13 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.13
Piotroski F-Score	5